S. Bailly

Telomere Status of Advanced Non-Small-Cell Lung Cancer Offers a Novel Promising Prognostic and Predictive Biomarker

J. Bay, G. Jeannin, A. Cayre, 2022, Cancers.

Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study

A. Ginzac, X. Durando, I. Molnar, 2021, Cancer medicine.

Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers

P. Gaulard, G. Salles, R. Bouabdallah, 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

TCL1 expression patterns in Waldenström macroglobulinemia

P. Morel, X. Leleu, J. Bay, 2016, Modern Pathology.

[Major therapeutic advances and new perspectives in onco-hematology].

J. Bay, P. Verrelle, O. Tournilhac, 2013, Bulletin du cancer.

Satisfaction of Cancer Patients Treated with Oral Anticancer Medications regarding Dispensing by Community Pharmacists: A Cross-Sectional Study

J. Bay, C. Pétorin, D. Balayssac, 2023, European Journal of Cancer Care.

The TGF‐β Pathway as an Emerging Target for Chagas Disease Therapy

S. Bailly, J. Feige, M. Waghabi, 2012, Clinical pharmacology and therapeutics.

Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.

S. Bailly, J. Timsit, J. Mira, 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[Major therapeutic advances and new perspectives in onco-hematology].

P. Verrelle, J. Bay, J. Biau, 2013, Bulletin du cancer.